Method of inhibiting transformation of cells in which purine met

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514385, 514386, 514396, 514553, 514561, 514563, 514564, 514579, 514631, 514638, 514646, A01N 4354, A01N 4350, A61K 31415, A61K 31505

Patent

active

053247310

ABSTRACT:
A method of inhibiting growth, transformation and/or metastasis of mammalian cells, particularly epithelial cells, in which activity of at least one enzyme, which participates in purine metabolism or regulation of nucleotide levels or the relative ratios of their phosphorylated states, is elevated. In particular, a method of inhibiting transformation, growth and/or metastasis of mammalian cells in which a DNA tumor virus, a DNA tumor virus factor or other factor which has an equivalent effect on cells has acted.

REFERENCES:
El Hiyani, L. et al., Biological Abstracts, 84(9): AB-729, No. 89661 (1987). and Chem.-Biol. Interactions, 62: 167-178 (1987).
Toleikis, A. I. et al., Biological Abstracts, 86(11): AB-170, No. 110912 (1988) and Biokhimiya, 53(4): 649-654 (1988).
Moss, R. J. et al., J. Med. Chem., 31: 786-790 (1988).
Kappler, F. et al., J. Med. Chem., 25: 1179-1184 (1982).
Miranda, A. F. et al., Proc. Natl. Acad. Sci., USA, 80: 6581-6585 (1983).
Rubery, E. D. et al., Biological Abstracts, 76(5): 3844, No. 35410 (1983) and Eur. J. Cancer Clin. Oncol. 18(10): 951-956 (1982).
Gazdar, A. F. et al., Biological Abstracts, 805: AB-578, No. 578, No. 41779 (1985) and Cancer Res., 45(6): 2924-2930 (1985).
van der Krol., A. R., J. N. M. Mol, and A. R. Stuitje, BioTechniques, 6(10): 958-976 (1988).
Maker, H. S. et al., Biological Abstracts, 78(2): 1470, No. 12908 (1984), and Res. Comm. Chem. Pathol. Pharmacol., 40(3): 355-366 (1983).
Daouk, G. H. et al., J. Biol. Chem., 263(5): 2442-2446 (Feb. 15, 1988).
Lillie, J. W. et al., Cell, 50: 1091-1100 (1987).
Inhorn, L. et al., Biological Abstrcats, 86(2): AB-700, No. 17059 (1988) and Blood, 71(4): 1003-1011 (1988).
Rivedal, E. and T. Sanner, Chemical Abstracts, 103(9): 50, No. 153568m (1985) and Cancer Lett., 28(1): 9-17 (1985).
Folbergrova, J. et al., Biological Abstracts, 84(2): AB-684, No. 17158 (1987) and Neoplasma, 34(1): 3-14 (1987).
Mariman, E. C. M. et al., Genomics, 1:126-137 (1987).
Mariman, E. C. M. et al., Nucl. Acids Res., 17: 6385 (1989).
Zerler, B. et al., Mol. Cell. Biol., 7: 821-829 (1987).
Shields, R. P. et al., Lab. Invest., 33: 151-158 (1975).
McLaughlin, A. C. et al., J. Biol. Chem., 247: 4382-4388 (1972).
Johnston, J. B. et al., Cancer Res., 46: 2179-2184 (1986).
Kaddurah-Daouk, R. et al., Mol. Cell. Biol., 10(4): 1476-1483 (1990).
Feld, R. and Witte, D. L., Clin. Chem., 23(10): 1930-1932 (1977).
Annesley, T. M. and J. B. Walker, J. Biol. Chem., 253: 8120-8125 (1978).
Silverman, L. M. et al., Clin. Chem., 25(8): 1432-1435 (1979).
Gazdar, A. F. et al., Cancer Res., 41: 2773-2777 (1981).
Carney, D. N. et al., Cancer Res., 44: 5399-5403 (1984).
Carney, D. N. et al., Cancer Res., 45: 2913-2923 (1985).
Lillie, J. W. et al., Cell, 46: 1043-1051 (1986).
Moran, E. and M. B. Mathews, Cell, 48: 177-178 (1987).
White, P. et al., Nature, 334: 124-129 (Jul. 1988).
Kaye, F. J. et al., J. Clin. Invest., 79: 1412-1420 (1987).
Phelps, W. C. et al., Cell 53: 539-547 (May, 1988).
Phelps, W. C. et al., Functional and Sequence Similarities Between HPV-16 E7 and Adenovirus E1A, In: Transforming Proteins of DNA tumor Viruses, Current Topics in Microbiol. and Immunol., vol. 144, (1989), R. Knippers and A. J. Kevine (Eds.), Springer-Verlag, Berlin, pp. 153-166.
von Knebel Doeberitz, M. et al;, Cancer Res., 48: 3780-3786, (Jul. 1988).
Kleinheinz et al., Human Papillomavirus Early Gene Products and Maintenance of the Transformed State of Cervical Cancer Cells In Vitro, In: Transforming Proteins of DNA Tumor Viruses, Current Topics in Microbiol. and Immunol., vol. 144, (1989), R. Knippers and A. J. levine (eds.), Springer-Verlag, Berlin, pp. 179-179.
Dyson, N. et al., Science, 243: 934-937 (Feb. 17, 1989).
Ch'ng, J. L. C. et al., Proc. Natl. Acad. Sci, U.S.A., 86: 10006-10010 (Dec. 1989).
Colberg-Poley, A. M. and Santomenna, L. D., Virology, 166(1):217-228 (1988).
Ishiguro, Y. et al., Cancer, 65: 2014-2019 (May 1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of inhibiting transformation of cells in which purine met does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting transformation of cells in which purine met, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting transformation of cells in which purine met will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2377610

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.